Literature DB >> 7153710

Lysis of antibody-coated cells by platelets.

W D Soper, S P Bartlett, H J Winn.   

Abstract

Antibody-coated erythrocytes are lysed by murine C5- whole blood but not by plasma separated from such blood. The lytic activity has been shown to derive from platelets that attach to sensitized cells probably through membrane receptors for C3b. Whole blood or platelet-rich plasma (prp) obtained from mice that have been treated with purified cobra venom factor has little or no activity unless it is fortified with fresh C5- plasma. Lysis is observed only if the reactants are incubated at 37 degrees C and mechanical shaking is practiced, at least intermittently, throughout the period of incubation. Adherence of platelets and subsequent lysis are mediated by antibodies of a variety of immunoglobulin classes, including those that fail to mediate complement-dependent lysis. Platelet-mediated lysis is limited to cells to which the platelets adhere; 51Cr labeled, unsensitized cells that are mixed with prp and sensitized, unlabeled cells do not release 51Cr. Normal murine lymphoid cells and ascites tumor cells of mice, rats, and guinea pigs were apparently unaffected by sensitization and incubation with prp. However, because adherence of platelets to these sensitized cells was not observed, it is not clear whether the cells are resistant to the lytic action of platelets or whether the conditions of incubation were unfavorable for the attachment of platelets to the surfaces of nucleated cells. The significance of the lytic reaction described here is not known but may lie in antibody mediated release of microbicidal substances from platelets.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153710      PMCID: PMC2186810          DOI: 10.1084/jem.156.4.1210

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

2.  In vitro studies of immunologically induced secretion of mediators from cells and related phenomena.

Authors:  E L Becker; P M Henson
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

Review 3.  Immunologic mechanisms of platelet damage.

Authors:  A G Osler; R P Siraganian
Journal:  Prog Allergy       Date:  1972

4.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

5.  Antibody-mediated suppression of tumor growth. II. Macrophage and platelet cooperation with murine IgG1 isolated from alloantiserum.

Authors:  R J Johnson; G R Pasternack; H S Shin
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

6.  Comparative bactericidal activities of blood serum and plasma serum.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1960-07-01       Impact factor: 14.307

  6 in total
  10 in total

1.  Cells within the vascular system capable of mediating trypanocidal activity in vitro.

Authors:  K T Shaw; Y Mawji; M M Stevenson; P A Kongshavn
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Human platelet inhibition of Toxoplasma gondii growth.

Authors:  B F Chumpitazi; J Simon; B Polack; F Peyron; S Picot; J Ricard; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  Platelets in allergy. Assays and interpretation.

Authors:  M Joseph
Journal:  Clin Rev Allergy       Date:  1988

4.  Reversal of antibody-dependent cellular cytotoxicity suppression by cycloheximide.

Authors:  G Serebrinsky; M A Isturiz
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

5.  Acute antibody-mediated rejection of skin grafts without involvement of granulocytes or complement.

Authors:  M J Bogman; I M Cornelissen; R A Koene
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

Review 6.  Of mice and men: the relevance of the mouse to the study of human SLE.

Authors:  D J Birmingham; B H Rovin; C Y Yu; L A Hebert
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

7.  Platelet-mediated cytotoxicity. Role of antibody and C3, and localization of the cytotoxic system in membranes.

Authors:  S Slezak; D E Symer; H S Shin
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

8.  Human platelets effectively kill K-562 cells, a chronic myelogenic leukemia cell line, in vitro.

Authors:  T Sagawa; T Kodama; A Tominaga; M Okada
Journal:  Jpn J Cancer Res       Date:  1990-05

9.  Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane.

Authors:  E C Yong; E Y Chi; T R Fritsche; W R Henderson
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  A requirement for membrane-associated phospholipase A2 in platelet cytotoxicity activated by receptors for immunoglobulin G and complement.

Authors:  D E Symer; W A Paznekas; H S Shin
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.